CSIMarket
 


Atara Biotherapeutics Inc   (ATRA)
Other Ticker:  
 
 

ATRA's Revenue Growth by Quarter and Year

Atara Biotherapeutics Inc 's Revenue results by quarter and year




ATRA Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.22 7.55 0.00
III Quarter September 5.49 4.46 5.37 0.00
II Quarter June 3.61 51.58 3.87 0.00
I Quarter March 4.25 7.31 3.55 0.00
FY   13.35 63.57 20.34 0.00



ATRA Revenue third quarter 2023 Y/Y Growth Comment
Atara Biotherapeutics Inc reported Revenue improvement of 23.18% year on year in the third quarter 2023, to $ 5.49 millions, this is lower than Atara Biotherapeutics Inc 's recent average Revenue rise of 50.06%.

Looking into third quarter 2023 results within Biotechnology & Pharmaceuticals industry 6 other companies have achieved higher Revenue growth. While Atara Biotherapeutics Inc ' s Revenue rise of 23.18% ranks overall at the positon no. 977 in the third quarter 2023.




ATRA Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - -97.09 % - -
III Quarter September 23.18 % -16.95 % - -
II Quarter June -93 % 1232.82 % - -
I Quarter March -41.86 % 105.92 % - -
FY   - 212.54 % - -

Financial Statements
Atara Biotherapeutics Inc 's third quarter 2023 Revenue $ 5.49 millions ATRA's Income Statement
Atara Biotherapeutics Inc 's third quarter 2022 Revenue $ 4.46 millions Quarterly ATRA's Income Statement
New: More ATRA's historic Revenue Growth >>


ATRA Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -95.07 % 40.6 % -
III Quarter September 52.19 % -91.35 % 38.76 % -
II Quarter June -15.06 % 605.61 % 9.01 % -
I Quarter March 1831.82 % -3.18 % - -
FY (Year on Year)   - 212.54 % - -




Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #7
Healthcare Sector #113
Overall #977

Revenue Y/Y Growth Statistics
High Average Low
212.55 % 50.06 % -82.53 %
(Dec 31 2022)   (Jun 30 2023)
Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #7
Healthcare Sector #113
Overall #977
Revenue Y/Y Growth Statistics
High Average Low
212.55 % 50.06 % -82.53 %
(Dec 31 2022)   (Jun 30 2023)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Atara Biotherapeutics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
1824.89 % 236.59 % -95.04 %
(Mar 31 2023)  


ATRA's III. Quarter Q/Q Revenue Comment
Atara Biotherapeutics Inc achieved in the III. Quarter 2023 below company average Revenue jump of 52.19% quarter on quarter, to $ 5.49 millions.

III. Quarter 2023 Atara Biotherapeutics Inc 's results appear to be contradictory, although beneath the average, yet it presents real recovery relative to the -91.35% in the III. Quarter 2022 Aaliyah L. Thomas, a business advisor from Houston said.

Within Biotechnology & Pharmaceuticals industry 23 other companies have achieved higher Revenue quarter on quarter growth. While Atara Biotherapeutics Inc 's Revenue growth quarter on quarter, overall rank is 204.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #24
Healthcare Sector #91
Overall #204
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #24
Healthcare Sector #91
Overall #204
Revenue Q/Q Growth Statistics
High Average Low
1824.89 % 236.59 % -95.04 %
(Mar 31 2023)  


ATRA's III. Quarter Q/Q Revenue Comment
Atara Biotherapeutics Inc achieved in the III. Quarter 2023 below company average Revenue jump of 52.19% quarter on quarter, to $ 5.49 millions.

Although the III. Quarter 2023 ATRA's Revenue Q/Q growth was beneath the ordinary , it was yet good sign, as the current improvement, transcends the -91.35% Revenue growth in the same quarter a year ago

Within Biotechnology & Pharmaceuticals industry 23 other companies have achieved higher Revenue quarter on quarter growth. While Atara Biotherapeutics Inc 's Revenue growth quarter on quarter, overall rank is 204.


Atara Biotherapeutics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Revenue 12 Months Ending $ 13.58 $ 12.54 $ 60.51 $ 63.57 $ 70.90
Y / Y Revenue Growth (TTM) -80.85 % -82.53 % 151.07 % 212.55 % -
Year on Year Revenue Growth Overall Ranking # 19 # 50 # 52 # 0 # 0
Seqeuential Revenue Change (TTM) 8.25 % -79.27 % -4.81 % -10.33 % -1.27 %
Seq. Revenue Growth (TTM) Overall Ranking # 2342 # 610 # 564 # 0 # 921




Cumulative Revenue growth Comment
Atara Biotherapeutics Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2023. If the fiscal year would end in Sep 30 2023, Atara Biotherapeutics Inc 's annual Revenue decline would be -80.85% year on year to $14 millions.

Among companies within the Healthcare sector 5 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 19, from total ranking in previous quarter at 50.

Revenue TTM Q/Q Growth Statistics
High Average Low
212.55 %
50.06 %
-82.53 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 35
Healthcare Sector # 6
Overall # 19

Revenue TTM Y/Y Growth Statistics
High Average Low
212.55 %
50.06 %
-82.53 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 35
Sector # 377
S&P 500 # 2342
Cumulative Revenue growth Comment
Atara Biotherapeutics Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2023. If the fiscal year would end in Sep 30 2023, Atara Biotherapeutics Inc 's annual Revenue drop would be -80.85% year on year to $14 millions.

Among companies within the Healthcare sector 5 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 19, from total ranking in previous quarter at 50.

Revenue TTM Q/Q Growth Statistics
High Average Low
212.55 %
50.06 %
-82.53 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 35
Healthcare Sector # 6
Overall # 19

Revenue TTM Y/Y Growth Statistics
High Average Low
212.55 %
50.06 %
-82.53 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 35
Sector # 377
S&P 500 # 2342




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ATRA's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ATRA's Competitors
Revenue Growth for Atara Biotherapeutics Inc 's Suppliers
Revenue Growth for ATRA's Customers

You may also want to know
ATRA's Annual Growth Rates ATRA's Profitability Ratios ATRA's Asset Turnover Ratio ATRA's Dividend Growth
ATRA's Roe ATRA's Valuation Ratios ATRA's Financial Strength Ratios ATRA's Dividend Payout Ratio
ATRA's Roa ATRA's Inventory Turnover Ratio ATRA's Growth Rates ATRA's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2023
Aadi Bioscience Inc 40.38%$ 40.377 millions
Inspire Medical Systems inc 40.05%$ 40.052 millions
Omega Therapeutics Inc 39.66%$ 39.664 millions
Janux Therapeutics Inc 38.83%$ 38.831 millions
Viemed Healthcare Inc 38.15%$ 38.153 millions
Mersana Therapeutics Inc 38.13%$ 38.130 millions
Eli Lilly And Company36.84%$ 36.836 millions
Progyny Inc 36.64%$ 36.642 millions
Harmony Biosciences Holdings inc 36.49%$ 36.488 millions
Lantheus Holdings Inc 33.29%$ 33.289 millions
Lifeloc Technologies Inc 32.66%$ 32.662 millions
Nephros Inc 32.59%$ 32.586 millions
Alphatec Holdings Inc 31.40%$ 31.398 millions
Axonics Inc 30.86%$ 30.859 millions
Inari Medical Inc 30.86%$ 30.856 millions
Rockwell Medical inc 30.52%$ 30.517 millions
Tela Bio Inc 30.05%$ 30.052 millions
Rapid Micro Biosystems Inc 29.67%$ 29.669 millions
Ontrak Inc 29.26%$ 29.265 millions
Adaptimmune Therapeutics Plc29.15%$ 29.150 millions
Bionano Genomics Inc 29.04%$ 29.040 millions
Talkspace Inc 29.04%$ 29.037 millions
Akoya Biosciences Inc 28.77%$ 28.771 millions
Neurocrine Biosciences Inc 28.59%$ 28.590 millions
Si bone inc 28.53%$ 28.530 millions
Medpace Holdings Inc 28.34%$ 28.341 millions
Caremax Inc 28.02%$ 28.016 millions
Acutus Medical Inc 27.41%$ 27.415 millions
Natera inc 27.38%$ 27.378 millions
Urogen Pharma Ltd 27.26%$ 27.260 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com